Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-28 | 2021-04-29 | 132660 |
TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132663 |
TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-25 | 132666 |
ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-02-12 | 132669 |
TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-01-28 | 2021-04-08 | 132672 |
TEVA-DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-02-05 | 2021-03-04 | 133441 |
EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2021-02-05 | 2021-03-11 | 133445 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-02-05 | 2021-03-11 | 133448 |
TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2021-02-05 | 2021-03-11 | 133453 |
CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-02-05 | 2021-04-29 | 133457 |
ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2021-02-05 | 2023-06-09 | 133460 |
TEVA-CLOBAZAM | 10MG | TABLET | Resolved | 2021-02-05 | 2021-02-11 | 133467 |
ACT EXEMESTANE | 25MG | TABLET | Resolved | 2021-02-05 | 2021-04-01 | 133470 |
TEVA-VARENICLINE | 0.5MG | TABLET | Actual shortage | 2021-02-05 | 2021-02-05 | 133473 |
TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-02-05 | 2021-02-25 | 133476 |
TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-11 | 2021-04-29 | 133770 |
TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-11 | 2021-05-27 | 133776 |
TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-02-11 | 2021-03-11 | 133779 |
TEVA-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2021-02-11 | 2021-03-25 | 133782 |
TEVA-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-02-11 | 2021-03-04 | 133785 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |